经查，周口市城乡开发投资有限公司于2022年8月至2023年4月分别发行了公司债券22周城03、23周城 01、23周城02和23周城04，并挂牌转让。但发行人在募集资金使用管理、信息披露方面，有关责任人在 职责履行方面，存在违规行为。 【大河财立方消息】12月29日，上交所披露纪律处分决定书，对周口市城乡开发投资有限公司及有关责 任人予以通报批评。 此外，发行人还有募集资金专户管理不规范的违规行为。上交所指出，2023年3月至4月，发行人将23周 城01募集资金6.107亿元从专户划转至一般户存放。此外，22周城03、23周城01、23周城02、23周城04 存在共用募集资金专户的情况。 最后，上交所还认定，发行人存在未如实、准确披露募集资金使用情况。纪律处分决定书显示，2023年 4月至2024年4月，发行人在2022年年报、2023年中报、2023年年报中，未如实、准确披露22周城03、23 周城01、23周城02、23周城04的募集资金使用及专户管理情况。此外，2024年7月19日，发行人披露临 时公告，称22周城03募集资金使用情况与约定用途一致，与实际情况不符。 根据上述违规行为，结合相关法律法规 ...

京源环保公告，公司收到江苏证监局行政监管措施决定书，指出公司存在违规使用募集资金支付非募投 项目费用的情况，且未在募集资金专项报告等公告中如实披露，导致信息披露不准确。此外，公司在 2024年年度报告中披露的法人治理状况与实际情况不符。根据决定书，公司及相关人员将被采取责令改 正和出具警示函的行政监管措施，并记入证券期货市场诚信档案。公司及相关人员将严格按照要求整 改，并在规定期限内提交书面整改报告。 ...

Core Viewpoint - Dongguan Kaige Precision Machinery Co., Ltd. (referred to as "Kaige Precision") has been found to have violated regulations by the Guangdong Securities Regulatory Commission, resulting in a corrective order and a warning letter issued to the company and four key personnel [1][3]. Group 1: Regulatory Violations - Kaige Precision misused IPO fundraising by allocating approximately 32.14 million yuan for salary payments, which is a violation of regulations [1]. - The company exceeded the planned salary payments for the "Research and Testing Center Project" by 26.91 million yuan, with actual salary payments amounting to 44.80 million yuan instead of the disclosed 17.89 million yuan [3]. - Additionally, the company improperly allocated 5.23 million yuan in salaries for temporary staff and interns unrelated to the "Precision Intelligent Manufacturing Equipment Production Base Construction Project" [5]. Group 2: Accountability and Response - Key personnel, including Chairman Qiu Guoliang and former executives, were held primarily responsible for the violations due to their failure to fulfill due diligence obligations as per the regulations [5]. - Kaige Precision has committed to rectifying the issues and improving the management of raised funds to enhance compliance awareness [6]. Group 3: Company Overview - Established in 2005, Kaige Precision specializes in the research, production, and sales of high-end precision automation equipment, with products used in various industries including consumer electronics and aerospace [6]. - The company reported a revenue of 454 million yuan for the first half of 2025, representing a year-on-year growth of 26.22%, and a net profit of 67.14 million yuan, up 144.18% year-on-year [6].

Group 1 - The Shenzhen Stock Exchange issued a regulatory letter to Zhejiang Liansheng Chemical Co., Ltd. regarding violations related to the management of raised funds, including purchasing financial products before the approval period and exceeding authorized limits [1] - The company reported inaccuracies in the disclosure of large time deposits in its special reports for the half-year and annual periods of 2023 and 2024 [1] - Key executives, including the chairman and general manager, failed to fulfill their duties and obligations, leading to violations of the listing rules [1] Group 2 - As of the report date, the market capitalization of Liansheng Chemical is 3 billion yuan [2] - The company's revenue composition for the year 2024 is entirely from fine chemicals, accounting for 100% [1]

Core Viewpoint - Jiangxi Mubang High-tech Co., Ltd. (hereinafter referred to as "the company") is facing regulatory scrutiny due to various violations related to financial disclosures and the use of raised funds, which may impact investor confidence and the company's operational integrity [4][10][13]. Group 1: Shareholder and Financial Issues - The controlling shareholder, Jiangxi Mubang New Energy Holdings Co., Ltd., holds 87,540,610 shares, accounting for 20.19% of the company's total equity. Recently, 470,610 shares were judicially frozen, bringing the total frozen shares to 2,833,874, which is 3.24% of its holdings and 0.65% of the company's total shares [2][16]. - The company has been found to have significant accounting errors, violating the disclosure management regulations, which has led to administrative measures from the Jiangxi Securities Regulatory Bureau [5][9]. - There have been instances of improper use of raised funds, where funds were diverted to related parties instead of being used for intended projects, constituting a violation of regulations [6][22]. Group 2: Regulatory Actions and Compliance - The company received an administrative penalty for failing to disclose non-operating fund occupations and for not adhering to proper disclosure protocols, which could lead to further regulatory actions if not rectified [10][11]. - The company is required to submit a rectification report within 30 days of receiving the regulatory decision, emphasizing the need for improved compliance and internal controls [10][11]. - The company has been notified of a formal investigation by the China Securities Regulatory Commission due to suspected false disclosures in annual reports, which could have serious implications for its operations and reputation [13][14]. Group 3: Impact on Operations and Governance - The freezing of shares and regulatory scrutiny is not expected to change the company's control structure or significantly impact its ongoing operations and governance [2][23]. - The company has stated that the recent pledge and unpledge of shares by the controlling shareholder will not affect its business operations or governance structure [16][23]. - The controlling shareholder's financial health is under scrutiny, with high debt levels and low liquidity ratios raising concerns about its ability to meet financial obligations [25][26].

Core Viewpoint - Jiangxi Mubang High-tech Co., Ltd. is under scrutiny from the Shanghai Stock Exchange regarding its 2024 annual report, particularly concerning the misuse of raised funds and significant internal control deficiencies, leading to substantial financial discrepancies and losses. Fund Misuse and Internal Control Issues - The company reported a significant misuse of raised funds amounting to 219.20 million yuan, which was used improperly for repaying bank loans and supplier debts through related party transactions [1][2][3] - Internal control audit revealed major deficiencies, with the internal control evaluation report indicating a non-financial report internal control defect involving 288.58 million yuan [1][2] - The company has faced multiple instances of fund freezing and judicial seizure, raising concerns about its financial management practices [1] Revenue Recognition and Financial Discrepancies - The company reported a revenue of 277.7 million yuan for the period, a drastic decrease of 83.24% year-on-year, resulting in a net loss of 1.162 billion yuan [4][5] - There were multiple corrections to accounting errors related to revenue recognition, particularly in the sales of toy raw materials and silicon wafers, leading to significant adjustments in reported figures [4][5][6] - The company acknowledged that the sales to related party Qiongcheng Qifeng Company were at inflated prices, necessitating a revenue adjustment of 118.41 million yuan due to the unreasonableness of the transaction [5][6][7] Supplier Relationships and Transaction Validity - The company is required to disclose detailed information about its top ten suppliers, including their relationships, contract details, and payment terms, to ensure transparency in its procurement processes [3][4] - The company has been instructed to clarify the commercial substance of transactions with related parties and ensure that all financial disclosures align with actual business practices [3][4][5] Adjustments in Accounting Practices - The company has shifted its accounting method for certain transactions from gross to net recognition, particularly in the ABS plastic trade, which has led to significant changes in reported revenue figures [8][9][10] - The adjustments in accounting practices were made to comply with accounting standards, ensuring that revenue recognition reflects the true nature of the transactions [8][9][10] Financial Position and Future Actions - As of the latest report, the company has a cash balance of approximately 687.57 million yuan, with significant receivables and inventory levels indicating ongoing liquidity challenges [18] - The company is expected to implement corrective measures to address the identified internal control deficiencies and ensure compliance with regulatory requirements moving forward [1][2][3]

Core Viewpoint - The report highlights the violations by Jiangxi Mubang High-Tech Co., Ltd. regarding the improper use of raised funds and non-operational fund occupation by related parties, necessitating corrective actions [1][11]. Group 1: Background and Findings - The special on-site inspection was conducted by Guojin Securities to investigate the misuse of raised funds and non-operational fund occupation by controlling shareholders and related parties [1]. - Abnormalities in prepaid accounts were noted, prompting the inspection from April 22 to April 30, 2025, and from May 12 to May 16, 2025 [1]. - The inspection revealed that funds were improperly used for non-investment projects, with a total of 261.44 million yuan misused, of which 229.68 million yuan occurred in 2024 [2][11]. Group 2: Specific Violations - In February 2024, 20 million yuan was transferred to the controlling shareholder through a series of transactions, constituting a violation of fund usage [3]. - In July, August, September, and November 2024, a total of 101.94 million yuan was prepaid to construction units, with part of the funds being used to repay loans and transferred to the controlling shareholder [3]. - In February 2025, 15 million yuan was improperly used from the raised funds for operational purposes [4]. Group 3: Recommendations and Corrective Actions - The company is required to report the amounts and periods of fund occupation by controlling shareholders and related parties within one month of the annual report disclosure [8]. - A qualified accounting firm should be engaged to verify the calculation of fund occupation fees and ensure compliance with disclosure obligations [8]. - The company must develop a solution for the improper use of raised funds within three months of the annual report disclosure and strengthen internal controls to prevent future violations [8][11].

塞力斯医疗科技集团股份有限公司 关于收到中国证券监督管理委员会湖北监管局 《行政处罚事先告知书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603716 证券简称：塞力医疗 公告编号：2025-026 债券代码：113601 债券简称：塞力转债 塞力斯医疗科技集团股份有限公司（以下简称"公司"）于2024年3月25日收到中国证券监督管理委员会 （以下简称"中国证监会"）下发的《立案告知书》（编号：证监立案字0052024002号）。因公司涉嫌信 息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证 监会决定对公司立案。具体内容详见公司于2024年3月26日在上海证券交易所网站发布的《关于收到中 国证券监督管理委员会立案告知书的公告》（公告编号2024-022）。 公司于2025年4月1日收到中国证监会湖北监管局下发的《行政处罚事先告知书》（编号：鄂处罚字 [2025]1号）。现就相关情况公告如下： 一、《行政处罚 ...